cefazolin has been researched along with Primary Peritonitis in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (24.29) | 18.7374 |
1990's | 13 (18.57) | 18.2507 |
2000's | 20 (28.57) | 29.6817 |
2010's | 17 (24.29) | 24.3611 |
2020's | 3 (4.29) | 2.80 |
Authors | Studies |
---|---|
Fujisaki, K; Kitazono, T; Nakano, T; Tachibana, S; Tomita, K; Torisu, K; Tsuchimoto, A; Tsuruya, K; Ueki, K | 1 |
Chen, B; Cui, T; Fang, X; He, Q; Ke, Y; Tian, L; Zheng, J; Zhu, W | 1 |
Al Sahlawi, M; Liew, A; Perl, J | 1 |
Chariyavilaskul, P; Kanjanabuch, T; Katavetin, P; Peerapornratana, S; Phaisal, W; Praditpornsilpa, K; Triyawatanyu, P | 1 |
Dinour, D; Kunin, M; Rosin, D | 1 |
Chen, YH; Chiu, YW; Hsu, CH; Huang, CH; Kuo, MC; Lee, CY; Lin, SY; Lu, PL; Wang, HH | 1 |
Hu, Z; Liu, X; Sun, X; Zuo, X | 1 |
Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
Eriguchi, M; Kasahara, K; Mikasa, K; Ogawa, Y; Samejima, K; Tsuruya, K; Yamada, A; Yano, H | 1 |
Boonyakrai, C; Chongthanakorn, K; Chuengsaman, P; Eiam-Ong, S; Halue, G; Johnson, DW; Kanjanabuch, T; Katavetin, P; Kitrungphaiboon, T; Matayart, S; Poonvivatchaikarn, U; Praditpornsilpa, K; Puapatanakul, P; Siribamrungwong, M; Somboonsilp, W; Tiskajornsiri, K | 1 |
Kim, JH; Kim, PK; Lee, JS; Lee, KO; Park, SJ; Shin, JI | 1 |
Alay, M; Buyukaydin, B; Erkoc, R; Iraz, M; Kazancioglu, R | 1 |
Cores-Calvo, O; Hernández-Egido, S; Puerta-Mateo, A; Ruiz-Ferraras, E | 1 |
Ahmad, M; Allen, V; Bargman, JM; Kelman, E; Krishnan, A | 1 |
Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T | 1 |
Chow, KM; Chung, KY; Kwan, BC; Law, MC; Leung, CB; Li, PK; Pang, WF; Szeto, CC | 1 |
Kavuncuoğlu, F; Oymak, O; Perçin, DE; Sipahioğlu, MH; Tokgöz, B; Unal, A; Utaş, C | 1 |
Gwak, WG; Shin, SJ | 1 |
Galetin, T; Lingohr, P; Rheinwalt, KP | 1 |
Fernando, G; Kennedy, KJ; Lawrence, M; Roberts, DM; Singer, RF; Talaulikar, G | 1 |
Bargman, JM; Heywood, A | 1 |
Changchien, CS; Chiou, SS; Chuah, SK; Hu, TH; Lu, SN; Tsai, MS; Wang, JH; Wu, KL; Xu, HW | 1 |
Crooke, P; Hota, S; Hotchkiss, J | 1 |
Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
Baker, RJ; Brown, EA; Clemenger, M; Senior, H | 1 |
Antosiewicz, S; Baczyński, D; Pietrzak, B; Wańkowicz, Z | 1 |
Hermsen, ED; Hotchkiss, JR; Hovde, LB; Rotschafer, JC | 1 |
Ariano, RE; Harding, GK; Strijack, C; Zelenitsky, SA | 1 |
Jung, SS; Kang, JM; Kim, H; Lee, KB; Lim, SH; Oh, SY; Park, HD | 1 |
Kleinpeter, MA | 1 |
Bailie, GR; Elwell, RJ; Manley, HJ; Welch, CL | 1 |
Gock, H; Langham, R; Mullins, K; Murphy, B; Snider, J; Toussaint, N | 1 |
Cheng, SW; Lai, KN; Lam, MF; Lo, WK; Lui, SL; Ng, F; Ng, SY; Tse, KC; Wan, KM; Yip, T | 1 |
Chow, KM; Chung, KY; Kwan, BC; Lau, MF; Law, MC; Leung, CB; Li, PK; Szeto, CC | 1 |
Aronoff, GR; Brier, ME; Bunke, CM; Luft, FC; Sloan, RS | 1 |
Claeys, G; De Paepe, M; Lameire, N; Verschraegen, G | 1 |
Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D | 1 |
Braga, B; Brazzoli, A; Depetri, G; Gazzotti, RM; Losio, R; Mileti, M; Usberti, M; Zucca, F | 1 |
Chiu, CK; Da Silva, MC; Karanfilian, RG; Karmakar, MG; Yang, HK | 1 |
Eyal, A; Greif, F; Lelcuk, S; Shalit, I | 1 |
Bren, AF; Gucek, A; Hergouth, V; Lindic, J | 1 |
Agraharkar, M; Galen, M; Klevjer-Anderson, P; Rubinstien, E | 1 |
Finkelstein, F; Gorban-Brennan, N; Kliger, A; Troidle, L | 1 |
Johnson, DW; Looke, D; Sturtevant, JM | 1 |
Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S; Torres, C | 1 |
Gadallah, MF; Mignone, J; Mitchell, L; Patel, D; Ramdeen, G; Tatro, S | 1 |
Azadian, B; Brown, EA; Clemenger, M; Goldberg, L | 1 |
Deville, JG; Fattal, O | 1 |
Bailie, GR; Crawford, TL; Diaz-Buxo, JA | 1 |
Havican, RG; Lamb, JM; Nahai, F; Stone, HH | 1 |
Courtis, GR; Fowler, R; Hewstone, AS; Raine, PA; Ritchie, MA | 1 |
McCloskey, RV; Sugar, AM | 1 |
Dawkins, EJ; Geheber, CE; Hooper, CA; Kolb, LD; Stone, HH | 1 |
Tauchnitz, C | 1 |
Berry, V; Mizen, L; Woodnutt, G | 1 |
Lee, EJ; Lye, WC; Tan, CC | 1 |
Kuhlmann, U; Weber, J | 1 |
Flanigan, MJ; Lim, VS | 1 |
Abramowicz, D; Amraoui, Z; Fiers, W; Goldman, M; Moulart, J; Nortier, J; Vandenabeele, P; Vanherweghem, JL | 1 |
Gloor, HJ; Lanzendörfer, H; Schmid, B; von Graevenitz, A; Wüst, J | 1 |
Kuhlmann, U; Machleidt, C; Mettang, T; Staerz, E; Weber, J | 1 |
Ben-Ezer Gradus, D; Benjamin, J; Chaimovitz, C; Mostoslavski, M; Rapoport, J | 1 |
Brown, E; Hendler, E | 1 |
Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
Binswanger, U; König, U; Müller, U | 1 |
Araki, H; Minami, S; Mitsuhashi, S; Saikawa, I; Takai, A; Watanabe, Y; Yasuda, T | 1 |
Bensoussan, A; De Meyer, P; Ducharme, G; Ducharme, JC | 1 |
Rukhliada, NV | 1 |
Lee, JT | 1 |
Calvin, S; Luis, ES; McDaid, T; Potter, D; Powell, D | 1 |
3 review(s) available for cefazolin and Primary Peritonitis
Article | Year |
---|---|
Peritonitis due to Moraxella osloensis: A case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Catheter-Related Infections; Catheters; Cefazolin; DNA, Bacterial; Humans; Male; Moraxella; Moraxellaceae Infections; Nephrosclerosis; Peritoneal Dialysis; Peritonitis; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Treatment Outcome | 2019 |
Listeria monocytogenes peritonitis in a patient on peritoneal dialysis: a case report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Humans; Listeria monocytogenes; Listeriosis; Peritoneal Dialysis; Peritonitis | 2008 |
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature.
Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
14 trial(s) available for cefazolin and Primary Peritonitis
Article | Year |
---|---|
Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
Topics: Anti-Bacterial Agents; Cefazolin; Cefepime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Treatment Outcome | 2019 |
Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; CA-125 Antigen; Cefazolin; Ceftazidime; Epithelial Cells; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Cavity; Peritoneal Dialysis; Peritonitis; Prospective Studies; Regression Analysis; Time Factors | 2004 |
Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intraperitoneal; Kidney Failure, Chronic; Male; Middle Aged; Outpatients; Peritoneal Dialysis; Peritonitis; Prospective Studies; Vancomycin | 2005 |
Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome | 2005 |
Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Topics: Adult; Aged; Cefazolin; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies | 1994 |
Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Topics: Cefazolin; Ceftazidime; Drug Therapy, Combination; Humans; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Treatment Failure; Vancomycin | 1997 |
Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cefazolin; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Staphylococcal Infections; Treatment Outcome | 1999 |
Preoperative vancomycin prophylaxis for newly placed peritoneal dialysis catheters prevents postoperative peritonitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Prospective Studies; Vancomycin | 2000 |
Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; Cephalosporins; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Prospective Studies; Urinary Catheterization; Vancomycin | 2000 |
Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
Topics: Adult; Aged; Aged, 80 and over; Cefazolin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome; Vancomycin | 2001 |
Antibiotic prophylaxis in gastric, biliary and colonic surgery.
Topics: Adolescent; Adult; Aged; Biliary Tract Surgical Procedures; Cefazolin; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Colon; Female; Georgia; Humans; Male; Middle Aged; Peritonitis; Postoperative Complications; Preoperative Care; Prospective Studies; Stomach; Surgical Wound Infection | 1976 |
Intraperitoneal cefazolin and gentamicin in the management of CAPD-related peritonitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cefazolin; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Time Factors | 1991 |
Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
Topics: Adult; Cefazolin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin | 1991 |
[Treatment of acute perforated appendicitis with intraperitoneal cefazolin].
Topics: Abscess; Acute Disease; Adolescent; Appendectomy; Appendicitis; Appendix; Cecal Diseases; Cefazolin; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Injections, Intraperitoneal; Male; Peritonitis; Postoperative Care; Postoperative Complications; Prospective Studies; Random Allocation; Surgical Wound Infection | 1986 |
53 other study(ies) available for cefazolin and Primary Peritonitis
Article | Year |
---|---|
A case of peritoneal dialysis-related peritonitis caused by dialysate leakage with successful treatment by intravenous and intraperitoneal antibiotic therapy.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Peritonitis | 2022 |
Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
Topics: Adult; Anti-Bacterial Agents; Anuria; Cefazolin; Ceftazidime; Dialysis Solutions; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies | 2023 |
Cefepime as Empirical Peritoneal Dialysis-Associated Peritonitis Treatment: Something to Dwell On?
Topics: Cefazolin; Cefepime; Ceftazidime; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2019 |
Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Topics: Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Dialysis Solutions; Female; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2020 |
Intraperitoneal antibiotic administration for prevention of postoperative peritoneal catheter-related infections.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections; Catheterization; Catheters, Indwelling; Cefazolin; Female; Humans; Male; Medical Records; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan.
Topics: Adult; Aged; Bacteria; Cefazolin; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Hospitals; Humans; Hyponatremia; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus; Taiwan | 2019 |
Effects of prophylactic antibiotics before peritoneal dialysis catheter implantation on the clinical outcomes of peritoneal dialysis patients.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cefazolin; China; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Retrospective Studies | 2019 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Child; Child, Preschool; Female; Humans; Infant; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tobramycin; Treatment Outcome | 2013 |
An unusual cause of peritonitis in peritoneal dialysis patients: Pantoea agglomerans.
Topics: Anti-Bacterial Agents; Cefazolin; Enterobacteriaceae Infections; Female; Humans; Middle Aged; Pantoea; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2014 |
[Moraxella osloensis peritonitis : Case report and review].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Humans; Moraxella; Moraxellaceae Infections; Peritoneal Dialysis; Peritonitis | 2016 |
Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Corynebacterium; Corynebacterium Infections; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Treatment Outcome; Vancomycin | 2009 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Netilmicin; Peritoneal Dialysis; Peritonitis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2009 |
[A rare cause of peritoneal dialysis-related peritonitis: Haemophilus influenzae].
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Leukocyte Count; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2009 |
Erysipelothrix rhusiopathiae peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Anti-Bacterial Agents; Cefazolin; Erysipelothrix; Erysipelothrix Infections; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2010 |
Acute abdomen due to vaginal impalement.
Topics: Abdomen, Acute; Adolescent; Anti-Infective Agents; Cefazolin; Coitus; Female; Humans; Laparoscopy; Metronidazole; Peritonitis; Vagina | 2010 |
Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefepime; Cephalosporins; Chemistry, Pharmaceutical; Dialysis Solutions; Drug Stability; Drug Storage; Humans; Peritoneal Dialysis; Peritonitis | 2011 |
Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporin Resistance; Coagulase; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 2010 |
The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Cefazolin; Cross Infection; Cross-Sectional Studies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Length of Stay; Liver Cirrhosis; Male; Peritonitis; Postoperative Complications; Recurrence; Retrospective Studies; Young Adult | 2011 |
A Monte Carlo analysis of peritoneal antimicrobial pharmacokinetics.
Topics: Anti-Infective Agents; Area Under Curve; Ascitic Fluid; Cefazolin; Ceftazidime; Clinical Trials as Topic; Computational Biology; Computer Simulation; Dialysis Solutions; Humans; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Peritoneal Dialysis; Peritonitis; User-Computer Interface | 2011 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Empirical aminoglycosides for peritonitis do not affect residual renal function.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Creatinine; Drug Administration Schedule; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Practice Guidelines as Topic; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Urea | 2003 |
[Empirical therapy of peritonitis in peritoneal dialysis patients--it is reasonable to use a new therapeutic schedule?].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporins; Cephradine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Poland; Retrospective Studies; Tobramycin; Treatment Outcome | 2002 |
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Colony Count, Microbial; Daptomycin; Dialysis Solutions; Hydrogen-Ion Concentration; Methicillin Resistance; Peritoneal Dialysis; Peritonitis; Protein Binding; Staphylococcus; Streptococcus; Vancomycin | 2003 |
Peritoneal fluid titer test for peritoneal dialysis-related peritonitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cephalosporins; Colony Count, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritoneal Dialysis; Peritonitis; Pilot Projects; Renal Dialysis; Reproducibility of Results; Tobramycin | 2004 |
Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD).
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Diabetic Nephropathies; Eosinophilia; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2004 |
Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Female; Humans; Kidney Failure, Chronic; Male; Methicillin Resistance; Middle Aged; Peritoneal Dialysis; Peritonitis; Risk Factors; Secondary Prevention; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2008 |
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Biological Availability; Cefazolin; Cephalexin; Female; Half-Life; Humans; Injections, Intraperitoneal; Kinetics; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1983 |
Gardnerella vaginalis (hemophilus vaginalis), an unusual cause of peritonitis in C.A.P.D.
Topics: Cefazolin; Female; Gardnerella vaginalis; Haemophilus Infections; Humans; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1982 |
Treatment of acute peritonitis by temporary discontinuation of dialysis and low doses of oral ciprofloxacin in patients on CAPD.
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Cefazolin; Ciprofloxacin; Clinical Protocols; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tobramycin | 1994 |
Laparoscopic management of peritonitis in the setting of an infected Tenckhoff catheter: a case report and description of technique.
Topics: Adult; Ascitic Fluid; Catheters, Indwelling; Cefazolin; Cephalosporins; Humans; Kidney Failure, Chronic; Laparoscopy; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Irrigation | 1996 |
Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
Topics: Acute Disease; Animals; Bacterial Infections; Cefazolin; Cefonicid; Cefotaxime; Cephalosporins; Drug Evaluation, Preclinical; Drug Monitoring; Peritoneal Cavity; Peritonitis; Random Allocation; Rats; Rats, Wistar; Tissue Distribution | 1996 |
Use of cefazolin for peritonitis treatment in peritoneal dialysis patients.
Topics: Cefazolin; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Retrospective Studies; Treatment Outcome | 1999 |
Treatment of peritoneal dialysis related peritonitis.
Topics: Cefazolin; Cephalosporins; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritonitis | 2000 |
Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; Escherichia; Gentamicins; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Peritonitis | 2000 |
Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Tobramycin | 2001 |
Factors involved in disruption of intestinal anastomoses.
Topics: Animals; Cefazolin; Colon; Dogs; Intestinal Mucosa; Intestine, Large; Intestine, Small; Jejunum; Peritonitis; Surgical Wound Dehiscence; Surgical Wound Infection; Suture Techniques; Transplantation, Autologous | 1977 |
The intraperitoneal use of cephazolin.
Topics: Adolescent; Appendicitis; Cefazolin; Cephalosporins; Child; Escherichia coli Infections; Humans; Ileum; Infant, Newborn; Intestinal Perforation; Peritoneal Cavity; Peritonitis; Therapeutic Irrigation | 1978 |
Bacillus licheniformis sepsis.
Topics: Bacillus; Cefazolin; Humans; Intestinal Perforation; Male; Middle Aged; Peritonitis; Sepsis | 1977 |
[The cephalosporins and their clinical value].
Topics: Abortion, Septic; Animals; Cefazolin; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Female; Humans; Mice; Penicillin Resistance; Penicillinase; Penicillins; Peritonitis; Pneumonia; Pregnancy; Staphylococcal Infections; Streptococcus; Urinary Tract Infections | 1976 |
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections | 1992 |
Prophylactic antibiotics in the insertion of Tenckhoff catheters.
Topics: Adult; Aged; Catheters, Indwelling; Cefazolin; Female; Gentamicins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Premedication; Prospective Studies | 1992 |
Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis.
Topics: Ascitic Fluid; Cefazolin; Female; Humans; Injections, Intraperitoneal; Interleukin-6; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin | 1990 |
Peritonitis caused by Actinomadura madurae in a patient on CAPD.
Topics: Adult; Amikacin; Cefazolin; Humans; Male; Mitosporic Fungi; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1990 |
Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
Topics: Catheters, Indwelling; Cefazolin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus epidermidis | 1989 |
Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefazolin; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Risk Factors; Vancomycin | 1989 |
Rhodococcus peritonitis in a patient treated with peritoneal dialysis.
Topics: Actinomycetales Infections; Cefazolin; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Rhodococcus; Vancomycin | 1989 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
[Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aspergillus; Bacteria; Candida; Cefazolin; Drug Combinations; Drug Resistance, Microbial; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
Topics: Animals; Ascitic Fluid; beta-Lactamases; Cefazolin; Cefmetazole; Cefoxitin; Cephalosporinase; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Enterobacter; Enterobacteriaceae Infections; Male; Mice; Mice, Inbred ICR; Peritonitis; Proteus Infections; Proteus vulgaris | 1986 |
[Preventive preoperative use of kanamycin and cefazolin in patients with acute intestinal obstruction].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefazolin; Female; Humans; Intestinal Obstruction; Kanamycin; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Premedication; Surgical Wound Infection | 1986 |
Three-year experience with amikacin sulfate as an exclusive surgical aminoglycoside in a large acute-care hospital.
Topics: Abdomen; Abscess; Amikacin; Ampicillin; Cefazolin; Clindamycin; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Gentamicins; Gram-Negative Bacteria; Hospital Bed Capacity, 500 and over; Hospitals, Veterans; Humans; Kanamycin; Male; Middle Aged; Minnesota; Penicillin Resistance; Peritonitis; Postoperative Complications; Premedication; Surgical Wound Infection | 1985 |
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine; Humans; Infant; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Tobramycin | 1985 |